Cancer patients are more likely to die if they use common antacid medicines with immunotherapiesSue DunlevyNews Corp Australia NetworkThu, 17 September 2020 3:26PMPremiumPremiumSubscribers with digital access can view this article.Already a subscriber?Login here.